Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Active Ulcerative Colitis
14%
Adalimumab
9%
Anti-tumor Necrosis Factor (anti-TNF)
10%
Bmal1
9%
Body Mass Index
22%
C-reactive Protein
8%
Celiac Disease
43%
Celiac Disease Autoimmunity
14%
Circadian Clock
9%
Clinical Outcomes
8%
Clock Gene Expression
10%
Clock Genes
23%
Confidence Interval
13%
Crohn's Disease
23%
CRY1
11%
Disease Activity
10%
Disease Course
11%
Disease Exacerbation
8%
Fecal Calprotectin
12%
Gene Disruption
15%
Gluten-free Diet
15%
Healthy Controls
9%
High Risk
9%
Histological Index
13%
Ileocolonoscopy
9%
Inflammation
10%
Inflammatory Bowel Disease
70%
Inflammatory Markers
12%
Infliximab
16%
Israel
10%
Maintenance Phase
9%
Newly Diagnosed
28%
Non-associated
11%
Obstructive Sleep Apnea
8%
Odds Ratio
8%
Pediatric
18%
Pediatric Inflammatory Bowel Disease
18%
Pediatric Patients
30%
Pediatric Ulcerative Colitis
18%
Per1
9%
Per2
10%
Remission
9%
Severe Disease
11%
Temporal Trends
9%
Tissue Transglutaminase Antibodies
9%
Ulcerative Colitis
33%
Ulcerative Colitis Patient
12%
Upper Quartile
9%
White Blood Cells
8%
Working Diagnosis
29%
Medicine and Dentistry
Abdominal Pain
7%
Acute Pancreatitis
7%
Adalimumab
18%
Adverse Event
7%
Allogeneic Hematopoietic Stem Cell Transplantation
7%
Alopecia Mucinosa
8%
Autoimmunity
7%
Blepharitis
7%
Body Mass Index
19%
C Reactive Protein
7%
Circadian Rhythm
8%
Coeliac Disease
44%
Crohn's Disease
25%
Disease Activity
12%
Disease Course
9%
Disease Exacerbation
8%
Diseases
13%
Elevated Transaminases
7%
Endoscopy
10%
Faecal Calprotectin
9%
Family History
7%
Gastrointestinal Endoscopy
15%
Gene Disruption
14%
Gene Targeting
14%
Gluten Free Diet
8%
Hepatology
8%
Histopathology
7%
Immunoglobulin A Antibody
8%
Inflammatory Bowel Disease
56%
Infliximab
12%
Juvenile Idiopathic Arthritis
7%
Leukocyte
10%
Metabolic Syndrome
7%
Nitrous Oxide
7%
Nutrition
8%
Observational Study
7%
Obstructive Sleep Apnea
7%
Patient with Crohn's Disease
15%
Patient with Inflammatory Bowel Disease
19%
Patient with Ulcerative Colitis
8%
Pediatric Gastroenterology
9%
Pediatrics
100%
Pediatrics Patient
28%
Prevalence
15%
Protein Glutamine Gamma Glutamyltransferase
10%
Retinol Deficiency
7%
Retrospective Study
23%
TNF Inhibitor
14%
Tumor Necrosis Factor
22%
Ulcerative Colitis
38%